The company announced today that it's going public through a reverse merger with a 13-year-old drugmaker from Danbury, Connecticut called Biodel ...
Growth Capitalist (https://growthcapitalist.com/2016/11/%E2%80%8Bbostons-newest-public-company-albireo-aims-to-treat-kids-liver-diseases/)
The company announced today that it's going public through a reverse merger with a 13-year-old drugmaker from Danbury, Connecticut called Biodel ...